申请人:ALZA CORPORATION
公开号:EP0037622A2
公开(公告)日:1981-10-14
An ocular insert is disclosed comprising a beta-adrenergic blocking osmotic drug solute and a parasympthomimetic osmotic drug solute dispersed in a polymer with the solutes surrounded by the polymer. The system, when placed in the eye, delivers both drugs at a controlled rate over time. A method also is disclosed for the management of intra- ocular pressure using the ocular system.
本发明公开了一种眼球植入物,包括分散在聚合物中的β-肾上腺素能阻断渗透药物溶质和拟副交感神经渗透药物溶质,溶质被聚合物包围。将该系统放入眼睛后,可在一段时间内以可控的速度输送这两种药物。此外,还公开了一种使用眼部系统管理眼内压的方法。